Opportunity ID: 324901

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-20-ARP-IDA
Funding Opportunity Title: DoD Autism, Idea Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Feb 27, 2020
Last Updated Date: Mar 19, 2020
Original Closing Date for Applications: Jul 16, 2020
Current Closing Date for Applications: Jul 28, 2020
Archive Date: Aug 15, 2020
Estimated Total Program Funding: $4,400,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.

The FY20 ARP Idea Development Award seeks applications from all areas of research. The ARP encourages applications that address the critical needs of the ASD community in one or more of the following areas:

• Tests of implementation strategies to increase use of evidence-based practices

• Development of healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief)

• Assessment of novel therapeutics using valid preclinical models

• Mechanisms of heterogeneous clinical expression of ASD

• Environmental risk factors

• Improve diagnosis across the life span

• Factors promoting success in key transitions to independence for individuals living with ASD

• Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services

• Mechanisms underlying sex differences in ASD diagnosis

• Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures)

• Factors impacting quality of life during geographic relocation, such as military permanent change of station

• Long-term treatment outcomes from previous clinical trials for ASD core symptoms or to alleviate co-occurring conditions

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date
This modification is to make changes to the Submission Dates and Times on Page 1 of the Program Announcement. Mar 19, 2020
Feb 27, 2020

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-20-ARP-IDA
Funding Opportunity Title: DoD Autism, Idea Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Feb 27, 2020
Last Updated Date: Mar 19, 2020
Original Closing Date for Applications: Jul 16, 2020
Current Closing Date for Applications: Jul 28, 2020
Archive Date: Aug 15, 2020
Estimated Total Program Funding: $4,400,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.

The FY20 ARP Idea Development Award seeks applications from all areas of research. The ARP encourages applications that address the critical needs of the ASD community in one or more of the following areas:

• Tests of implementation strategies to increase use of evidence-based practices

• Development of healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief)

• Assessment of novel therapeutics using valid preclinical models

• Mechanisms of heterogeneous clinical expression of ASD

• Environmental risk factors

• Improve diagnosis across the life span

• Factors promoting success in key transitions to independence for individuals living with ASD

• Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services

• Mechanisms underlying sex differences in ASD diagnosis

• Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures)

• Factors impacting quality of life during geographic relocation, such as military permanent change of station

• Long-term treatment outcomes from previous clinical trials for ASD core symptoms or to alleviate co-occurring conditions

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-20-ARP-IDA
Funding Opportunity Title: DoD Autism, Idea Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 27, 2020
Last Updated Date: Feb 27, 2020
Original Closing Date for Applications:
Current Closing Date for Applications: Jul 16, 2020
Archive Date: Aug 15, 2020
Estimated Total Program Funding: $4,400,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.

The FY20 ARP Idea Development Award seeks applications from all areas of research. The ARP encourages applications that address the critical needs of the ASD community in one or more of the following areas:

• Tests of implementation strategies to increase use of evidence-based practices

• Development of healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief)

• Assessment of novel therapeutics using valid preclinical models

• Mechanisms of heterogeneous clinical expression of ASD

• Environmental risk factors

• Improve diagnosis across the life span

• Factors promoting success in key transitions to independence for individuals living with ASD

• Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services

• Mechanisms underlying sex differences in ASD diagnosis

• Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures)

• Factors impacting quality of life during geographic relocation, such as military permanent change of station

• Long-term treatment outcomes from previous clinical trials for ASD core symptoms or to alleviate co-occurring conditions

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Folder 324901 Full Announcement-FY20 ARP IDA -> FY20 ARP IDA PA_GG2.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00258624 Feb 27, 2020 Jul 28, 2020 View

Package 1

Mandatory forms

324901 RR_SF424_2_0-2.0.pdf

324901 AttachmentForm_1_2-1.2.pdf

324901 RR_PersonalData_1_2-1.2.pdf

324901 RR_KeyPersonExpanded_2_0-2.0.pdf

324901 RR_Budget_1_4-1.4.pdf

324901 PerformanceSite_2_0-2.0.pdf

Optional forms

324901 RR_SubawardBudget30_1_4-1.4.pdf

2025-07-09T14:18:44-05:00

Share This Post, Choose Your Platform!

About the Author: